Diabetes in heart failure: prevalence and impact on outcome in the population.

PubWeight™: 2.09‹?› | Rank: Top 2%

🔗 View Article (PMID 16828631)

Published in Am J Med on July 01, 2006

Authors

Aaron M From1, Cynthia L Leibson, Francesca Bursi, Margaret M Redfield, Susan A Weston, Steven J Jacobsen, Richard J Rodeheffer, Véronique L Roger

Author Affiliations

1: The Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.

Articles citing this

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

Epidemiology and risk profile of heart failure. Nat Rev Cardiol (2010) 4.88

The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study. J Am Coll Cardiol (2010) 2.37

Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail (2012) 2.26

Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J Am Coll Cardiol (2009) 2.08

From Bedside to Bench: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Comorbidity and Multiple Morbidity in Older Adults. Aging Clin Exp Res (2008) 1.96

The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum (2008) 1.94

Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ Heart Fail (2010) 1.82

Trends in comorbidity, disability, and polypharmacy in heart failure. Am J Med (2011) 1.80

Sleep disordered breathing and post-discharge mortality in patients with acute heart failure. Eur Heart J (2015) 1.65

Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices. Eur J Heart Fail (2010) 1.49

Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev (2013) 1.44

An economic evaluation of a self-care intervention in persons with heart failure and diabetes. J Card Fail (2015) 1.39

Impact of comorbidity on mortality among older persons with advanced heart failure. J Gen Intern Med (2011) 1.31

Diabetic cardiomyopathy: bench to bedside. Heart Fail Clin (2012) 1.19

Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). J Cachexia Sarcopenia Muscle (2010) 1.10

Nonischemic heart failure in diabetes mellitus. Curr Opin Cardiol (2008) 1.09

Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial. Eur J Heart Fail (2012) 1.06

Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes (2015) 1.06

Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure. J Card Fail (2012) 1.02

Change in comorbidity prevalence with advancing age among persons with heart failure. J Gen Intern Med (2011) 1.00

Impact of diabetes on postinfarction heart failure and left ventricular remodeling. Curr Heart Fail Rep (2011) 0.96

Comorbid diabetes and end-of-life expenditures among Medicare beneficiaries with heart failure. J Card Fail (2011) 0.95

Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy. Eur Heart J (2009) 0.94

The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota. J Card Fail (2014) 0.93

Adverse association between diabetic retinopathy and cardiac structure and function. Am Heart J (2008) 0.92

Anaemia is an independent predictor of death in patients hospitalized for acute heart failure. Clin Res Cardiol (2010) 0.91

Obesity and cognitive dysfunction in heart failure: the role of hypertension, type 2 diabetes, and physical fitness. Eur J Cardiovasc Nurs (2014) 0.89

Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. Am J Cardiol (2009) 0.89

The cardiorenal syndrome in heart failure: cardiac? renal? syndrome? Heart Fail Rev (2012) 0.88

Heart failure in North America. Curr Cardiol Rev (2013) 0.87

Management of chronic heart failure in the older population. J Geriatr Cardiol (2014) 0.86

A pilot test of an integrated self-care intervention for persons with heart failure and concomitant diabetes. Nurs Outlook (2013) 0.85

Disturbed angiogenic activity of adipose-derived stromal cells obtained from patients with coronary artery disease and diabetes mellitus type 2. J Transl Med (2014) 0.85

Metabolic stress in the myocardium: adaptations of gene expression. J Mol Cell Cardiol (2012) 0.84

T(-786)→C polymorphism of the endothelial nitric oxide synthase gene is associated with insulin resistance in patients with ischemic or non ischemic cardiomyopathy. BMC Med Genet (2012) 0.83

Comparison of effects of sitagliptin and voglibose on left ventricular diastolic dysfunction in patients with type 2 diabetes: results of the 3D trial. Cardiovasc Diabetol (2015) 0.83

Usefulness of hemoglobin A(1c) to predict outcome after cardiac resynchronization therapy in patients with diabetes mellitus and heart failure. Am J Cardiol (2012) 0.82

Diabetic Cardiomyopathy; Summary of 41 Years. Korean Circ J (2015) 0.82

Assessment of cost and health resource utilization for elderly patients with heart failure and diabetes mellitus. J Card Fail (2010) 0.80

Subclinical Detection of Diabetic Cardiomyopathy with MicroRNAs: Challenges and Perspectives. J Diabetes Res (2015) 0.79

The microvascular effects of insulin resistance and diabetes on cardiac structure, function, and perfusion: a cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging (2014) 0.79

Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial. Cardiovasc Diabetol (2016) 0.79

Congestive heart failure and diabetes mellitus: balancing glycemic control with heart failure improvement. Am J Cardiol (2012) 0.79

CXCR4 Antagonism Attenuates the Development of Diabetic Cardiac Fibrosis. PLoS One (2015) 0.78

Non-cardiovascular comorbidity, severity and prognosis in non-selected heart failure populations: A systematic review and meta-analysis. Int J Cardiol (2015) 0.78

Weight and mortality following heart failure hospitalization among diabetic patients. Am J Med (2011) 0.78

The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise. Antioxid Redox Signal (2015) 0.78

Co-morbidities in heart failure. Heart Fail Rev (2014) 0.78

LncRNA H19 inhibits autophagy by epigenetically silencing of DIRAS3 in diabetic cardiomyopathy. Oncotarget (2016) 0.77

Epigenetic regulation in heart failure. Curr Opin Cardiol (2016) 0.76

The effect of chronic heart failure and type 2 diabetes on insulin-stimulated endothelial function is similar and additive. Vasc Health Risk Manag (2011) 0.76

Association of HbA1c with hospitalization and mortality among patients with heart failure and diabetes. BMC Cardiovasc Disord (2016) 0.75

High fat diet induces PKA and GRK phosphorylation of β2 -adrenergic receptor and impairs cardiac adrenergic reserve in animal hearts. J Physiol (2016) 0.75

Mortality Among Patients Hospitalized With Heart Failure and Diabetes Mellitus: Results From the National Inpatient Sample 2000 to 2010. Circ Heart Fail (2016) 0.75

Is Diabetes Mellitus a Risk Factor for Poor Outcomes after Left Ventricular Assist Device Placement? Tex Heart Inst J (2017) 0.75

A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus. Vasc Health Risk Manag (2007) 0.75

Diabetic Cardiomyopathy: Current Approach and Potential Diagnostic and Therapeutic Targets. J Diabetes Res (2017) 0.75

Cardiogenic diabetes. Heart Fail Rev (2014) 0.75

[Diabetes and heart failure]. Herz (2010) 0.75

Dose Modification of Antidiabetic Agents in Patients with Type 2 Diabetes Mellitus and Heart Failure. Indian J Endocrinol Metab (2017) 0.75

Articles by these authors

Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98

Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89

Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med (2006) 17.13

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA (2003) 13.79

Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99

Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med (2004) 11.52

Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18

Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol (2004) 8.97

Trends in heart failure incidence and survival in a community-based population. JAMA (2004) 8.90

Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med (2012) 8.28

Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55

Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24

Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc (2012) 6.21

Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13

Systolic and diastolic heart failure in the community. JAMA (2006) 5.99

Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum (2005) 5.31

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26

Nurse staffing and inpatient hospital mortality. N Engl J Med (2011) 4.51

Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol (2008) 4.24

Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study. J Am Med Inform Assoc (2011) 4.20

Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol (2009) 4.16

Urologic diseases in America project: benign prostatic hyperplasia. J Urol (2005) 4.09

Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA (2005) 3.89

Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation (2007) 3.78

Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws. Arch Intern Med (2012) 3.77

Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol (2002) 3.68

Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol (2010) 3.63

Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol (2009) 3.42

Why patients visit their doctors: assessing the most prevalent conditions in a defined American population. Mayo Clin Proc (2013) 3.40

Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation (2005) 3.34

Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology (2007) 3.20

Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994. Arch Intern Med (2003) 3.13

Agreement between patient-reported symptoms and their documentation in the medical record. Am J Manag Care (2008) 3.08

The association between statin use and the diagnosis of prostate cancer in a population based cohort. J Urol (2010) 3.08

Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation (2010) 3.07

Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail (2010) 3.01

Pulmonary pressures and death in heart failure: a community study. J Am Coll Cardiol (2012) 2.98

A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up. Heart (2009) 2.96

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89

Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med (2002) 2.87

Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA (2011) 2.86

Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children. JAMA Pediatr (2013) 2.86

Unexplained pulmonary hypertension in elderly patients. Chest (2007) 2.85

Immunoreactivity and guanosine 3',5'-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide. Hypertension (2007) 2.77

Redefinition of myocardial infarction: prospective evaluation in the community. Circulation (2006) 2.76

The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum (2005) 2.74

Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol (2002) 2.74

Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ Res (2008) 2.73

Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin Proc (2013) 2.72

Agreement between patient reports of cardiovascular disease and patient medical records. Mayo Clin Proc (2005) 2.71

Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation (2009) 2.70

Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol (2005) 2.69

Atrial fibrillation and death after myocardial infarction: a community study. Circulation (2011) 2.63

Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation (2011) 2.63

Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol (2003) 2.62

Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation (2005) 2.61

Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity". J Am Coll Cardiol (2013) 2.61

Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology (2005) 2.60

Epidemiology of diastolic heart failure. Prog Cardiovasc Dis (2005) 2.59

Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res (2007) 2.56